Tdspharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	54,360	73,217	-	-	-	-
Enterprise Value	30,610	48,283	-	-	-	-
Last Close Price	9830.00	13240.00	-	-	-	-
PE Ratio	15.85	19.69	-	-	-	-
PS Ratio	2.21	2.66	-	-	-	-
PB Ratio	1.32	1.90	-	-	-	-
P/TBV Ratio	1.32	1.91	-	-	-	-
P/FCF Ratio	60.75	22.79	-	-	-	-
P/OCF Ratio	25.86	18.64	-	-	-	-
EV/Sales Ratio	1.25	1.76	-	-	-	-
EV/EBITDA Ratio	9.66	10.98	-	-	-	-
EV/EBIT Ratio	12.50	12.95	-	-	-	-
EV/FCF Ratio	34.21	15.03	-	-	-	-
Debt / Equity Ratio	0.16	0.18	0.31	0.38	0.44	0.43
Debt / EBITDA Ratio	2.04	1.57	1.18	1.38	2.01	2.49
Debt / FCF Ratio	7.21	2.15	2.32	3.00	2.05	3.56
Asset Turnover	0.48	0.66	0.93	0.89	0.74	0.72
Inventory Turnover	5.82	7.02	9.51	9.49	8.63	8.30
Quick Ratio	3.54	3.46	2.18	1.59	1.16	1.14
Current Ratio	3.82	3.77	2.43	1.83	1.37	1.34
Return on Equity (ROE)	8.30%	12.10%	22.73%	20.06%	12.70%	9.59%
Return on Assets (ROA)	3.01%	5.61%	9.73%	8.23%	5.40%	4.06%
Return on Invested Capital (ROIC)	12.53%	22.18%	28.30%	22.29%	12.65%	8.48%
Return on Capital Employed (ROCE)	5.90%	9.70%	21.00%	18.30%	13.30%	9.30%
Earnings Yield	6.04%	5.08%	-	-	-	-
FCF Yield	1.65%	4.39%	-	-	-	-
Buyback Yield / Dilution	-20.99%	-8.74%	0.07%	-4511.34%	7.60%	0.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.